Margaret C Wardle1, Amy Yang, Harriet de Wit. 1. Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S. Maryland Ave, MC 3077, Chicago, IL 60637, USA.
Abstract
RATIONALE: Post-error slowing has long been considered a sign of healthy error detection and an important component of cognitive function. However, the neuropharmacological processes underlying post-error slowing are poorly understood. OBJECTIVES: This study investigated the effect of the dopamine agonist d-amphetamine on post-error slowing and secondarily, the potential mediator of drug-induced euphoria and potential moderators of personality and baseline task performance. METHODS:Healthy male and female participants (N = 110) completed four study sessions, at which d-amphetamine (placebo 5, 10, 20 mg) was administered under double-blind, counter-balanced conditions. At each session, participants completed subjective drug effect assessments and a working memory task (N-back) to measure post-error slowing. They completed the Multidimensional Personality Questionnaire (MPQ) during screening. RESULTS:Amphetamine (20 mg) reduced post-error slowing, consistent with a dampened behavioral reactivity to errors. This was not related to drug-induced euphoria. Although higher scores on MPQ constraint were related to less post-error slowing under placebo conditions, neither personality nor baseline cognitive performance moderated the effects of amphetamine on post-error slowing. CONCLUSIONS: The finding that amphetamine reduced post-error slowing supports the idea that dopamine plays a role in error stimulus processing. The finding is discussed in relation to an existing literature on the mechanisms and function of behavioral and electrophysiological indices of error sensitivity.
RCT Entities:
RATIONALE: Post-error slowing has long been considered a sign of healthy error detection and an important component of cognitive function. However, the neuropharmacological processes underlying post-error slowing are poorly understood. OBJECTIVES: This study investigated the effect of the dopamine agonist d-amphetamine on post-error slowing and secondarily, the potential mediator of drug-induced euphoria and potential moderators of personality and baseline task performance. METHODS: Healthy male and female participants (N = 110) completed four study sessions, at which d-amphetamine (placebo 5, 10, 20 mg) was administered under double-blind, counter-balanced conditions. At each session, participants completed subjective drug effect assessments and a working memory task (N-back) to measure post-error slowing. They completed the Multidimensional Personality Questionnaire (MPQ) during screening. RESULTS:Amphetamine (20 mg) reduced post-error slowing, consistent with a dampened behavioral reactivity to errors. This was not related to drug-induced euphoria. Although higher scores on MPQ constraint were related to less post-error slowing under placebo conditions, neither personality nor baseline cognitive performance moderated the effects of amphetamine on post-error slowing. CONCLUSIONS: The finding that amphetamine reduced post-error slowing supports the idea that dopamine plays a role in error stimulus processing. The finding is discussed in relation to an existing literature on the mechanisms and function of behavioral and electrophysiological indices of error sensitivity.
Authors: J H Callicott; V S Mattay; A Bertolino; K Finn; R Coppola; J A Frank; T E Goldberg; D R Weinberger Journal: Cereb Cortex Date: 1999 Jan-Feb Impact factor: 5.357
Authors: Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger Journal: Proc Natl Acad Sci U S A Date: 2003-04-25 Impact factor: 11.205
Authors: Ellen R A de Bruijn; Wouter Hulstijn; Robbert J Verkes; Gé S F Ruigt; Bernard G C Sabbe Journal: Psychopharmacology (Berl) Date: 2004-05-15 Impact factor: 4.530
Authors: Petra H J M Vlamings; Lisa M Jonkman; Marco R Hoeksma; Herman van Engeland; Chantal Kemner Journal: Eur J Neurosci Date: 2008-07 Impact factor: 3.386
Authors: Patrick J Zirnheld; Christine A Carroll; Paul D Kieffaber; Brian F O'Donnell; Anantha Shekhar; William P Hetrick Journal: J Cogn Neurosci Date: 2004 Jul-Aug Impact factor: 3.225
Authors: Jessica J M Barnes; Redmond G O'Connell; L Sanjay Nandam; Angela J Dean; Mark A Bellgrove Journal: Psychopharmacology (Berl) Date: 2013-08-31 Impact factor: 4.530
Authors: Xi Luo; Sheng Zhang; Sien Hu; Sarah R Bednarski; Emily Erdman; Olivia M Farr; Kwang-Ik Hong; Rajita Sinha; Carolyn M Mazure; Chiang-Shan R Li Journal: Brain Date: 2013-03-12 Impact factor: 13.501